A Clinical Study of Kumkum Nasya and Pathyadi Shadanga Kwatha in the management of Ardhavabhedaka with special reference to Migraine: A Randomized Clinical Trial - A Research Protocol
Abstract
The lifestyle of the people of the modern era has changed due to rapid urbanization. Due to changes in lifestyle, stress is causing an increased incidence of acute and chronic disorders like Ardhavabhedaka. Ardhavabhedaka (Migraine) is a condition associated with moderate to severe headaches with a throbbing type of pain that lasts from hours to days. It begins on one side of the head and spread to both temporal, and occipital regions and is frequently accompanied by symptoms such as nausea and vomiting, tiredness, and sometimes giddiness. Ardhavabhedaka can be correlated with migraine, due to its cardinal features of a half-sided headache. According to Acharya Charaka Ardhavabhedaka have Vata-Kapha dosha. The management of these Dosha can be done through Kumkum Nasya Karma.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.